Rak jelita grubego: badanie kliniczne

Kryteria włączenia kto może wziąć udział (13)

1. Men and women, age 40 years or older with endoscopic removal (snare or forceps polypectomy; endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) with R1 (resection margin <0.1mm23,40) or Rx resection margins of colon cancer (location proximal to the rectum (12 cm or more from the anal verge))
2. No contraindication for colon surgery as deemed by the multidisciplinary tumor board (MTB) at the participating centre
3. Absence of the following histopathological tumor features: poor differentiation, lymphovascular invasion, tumor budding grade B2-B3.
4. No sign of disease beyond stage T1N0M0 on standard-of-care computed tomography imaging of the thorax, abdomen and pelvis41 and clinical evaluation
5. Identifiable resection site with colonoscopy, either by visualizing a previously administered tattoo or by identification of a scar in the correct colon segment
6. No other tumors or polyps larger than 10 mm in diameter in the colorectum at time of randomization
7. Complete colonoscopy with adequate quality of bowel preparation (Boston Bowel Preparation Scale score ≤2 in all colonic segments) and photo or video documentation of the appendiceal orifice or ileocecal valve.
8. No colonic strictures or severe diverticulosis.
9. No prior CRC
10. No other malignant disease which is not deemed cured
11. No confirmed or suspected genetic cancer syndrome (10 or more adenomas/serrated lesions, adenomatous or serrated polyposis syndrome; Lynch or Lynch-like syndrome)
12. No inflammatory bowel disease
13. Written informed consent provided by before enrolment